Paola Margutti

Dr. Paola Margutti


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Autoimmunity Reviews
Verified
Journal Article
Closed access
ADAntonella D'Ambrosio
Antonella D'Ambrosio
SPSimona Pontecorvo
Simona Pontecorvo
TCTania Colasanti
Tania Colasanti
SZSilvia Zamboni
Silvia Zamboni
AFAda Francia
Ada Francia
PMPaola Margutti
Paola Margutti

9 October 2016 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
FDFederica Delunardo
Federica Delunardo
DSDenise Soldati
Denise Soldati
VBVeronica Bellisario
Veronica Bellisario
ABAlessandra Berry
Alessandra Berry
SCSerena Camerini
Serena Camerini
PMPaola Margutti
Paola Margutti

Verified
Journal Article
Open access
PDF file
PMPaola Margutti
Paola Margutti
ADAntonella D’ambrosio
Antonella D’ambrosio
SZSilvia Zamboni
Silvia Zamboni
The human microbiota is an intricate micro-ecosystem comprising a diverse range of dynamic microbial populations mainly consisting of bacteria, whose interactions with hosts strongly affect several physiological and pathological processes. The gut microbiota is being increasingly recognized as a critical player in maintaining homeostasis, contributing to the main functions of the intestine and distal organs such as the brain. However, gut dysbiosis, characterized by composition and function alterations of microbiota with intestinal barrier dysfunction has been linked to the development and progression of several pathologies, including intestinal inflammatory diseases, systemic autoimmune diseases, such as rheumatic arthritis, and neurodegenerative diseases, such as Alzheimer’s disease. Moreover, oral microbiota research has gained significant interest in recent years due to its potential impact on overall health. Emerging evidence on the role of microbiota–host interactions in health and disease has triggered a marked interest on the functional role of bacterial extracellular vesicles (BEVs) as mediators of inter-kingdom communication. Accumulating evidence reveals that BEVs mediate host interactions by transporting and delivering into host cells effector molecules that modulate host signaling pathways and cell processes, influencing health and disease. This review discusses the critical role of BEVs from the gut, lung, skin and oral cavity in the epithelium, immune system, and CNS interactions.

2 September 2024 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
ADAntonella D’ambrosio
Antonella D’ambrosio
SZSilvia Zamboni
Silvia Zamboni
SCSerena Camerini
Serena Camerini
MCMarialuisa Casella
Marialuisa Casella
MSMassimo Sanchez
Massimo Sanchez
PMPaola Margutti
Paola Margutti
Background and objectives: There is an urgent need to discover blood-based biomarkers of multiple sclerosis (MS) to better define the underlying biology of relapses and monitor disease progression. The main goal of this study is to search for candidate biomarkers of MS relapses associated with circulating extracellular vesicles (EVs), an emerging tool for biomarker discovery. Methods: EVs, purified from unpaired plasma and CSF samples of RRMS patients by size-exclusion chromatography (SEC), underwent proteomic analysis to discover novel biomarkers associated with MS relapses. The candidate biomarkers of disease activity were detected by comparison approach between plasma- and CSF-EV proteomes associated with relapses. Among them, a selected potential biomarker was evaluated in a cohort of MS patients, using a novel and highly reproducible flow cytometry-based approach in order to detect low abundant EV subsets in a complex body fluid such as plasma. Results: The proteomic profiles of both SEC-purified plasma EVs (from 6 patients in relapse and 5 patients in remission) and SEC-purified CSF EVs (from 4 patients in relapse and 3 patients in remission) revealed a set of proteins associated with MS relapses significant enriched in the synaptic transmission pathway. Among common proteins, excitatory amino-acid transporter 2, EAAT2, responsible for the majority of the glutamate uptake in CNS, was worthy of further investigation. By screening plasma samples from 110 MS patients, we found a significant association of plasma EV-carried EAAT2 protein (EV-EAAT2) with MS relapses, regardless of disease-modifying therapies. This finding was confirmed by investigating the presence of EV-EAAT2 in plasma samples collected longitudinally from 10 RRMS patients, during relapse and remission. Moreover, plasma EV-EAAT2 levels correlated positively with Expanded Disability Status Scale (EDSS) score in remitting MS patients but showed a negative correlation with age in patients with secondary progressive (SPMS). Conclusion: Our results emphaticize the usefulness of plasma EVs as a source of accessible biomarkers to remotely analyse the CNS status. Plasma EV-EAAT2 showed to be a promising biomarker for MS relapses. Further studies are required to assess the clinical relevance of this biomarker also for disability progression independent of relapse activity and transition from RRMS towards SPMS.

19 February 2023 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
SZSilvia Zamboni
Silvia Zamboni
ADAntonella D'AMbrosio
Antonella D'AMbrosio
PMPaola Margutti
Paola Margutti

30 June 1996 in Molecular and Cellular Probes
Verified
Journal Article
Closed access
Elena OrtonaElena Ortona
Elena Ortona
PMPaola Margutti
Paola Margutti
ALAndrea De Luca
Andrea De Luca
SPSarah E. Peters
Sarah E. Peters
AWAnn E. Wakefield
Ann E. Wakefield
ASAlessandra Siracusano
Alessandra Siracusano